Tag Archives: Johnson & Johnson
Johnson & Johnson Beats Q4 Sales Expectations, Expand More

Johnson & Johnson Exceeds Quarterly Sales Expectations, Maintains Outlook Johnson & Johnson (JNJ.US), a leading pharmaceutical and medical devices company, recently reported its fourth-quarter results, showcasing robust performance that surpassed analyst expectations. The company’s quarterly sales surged to $21.40 billion, accompanied by a net income of $4.13 billion. On a per-share basis, net earnings reached […]